SAFE Banking
Tax
Agriculture
Duration: May 15, 2018
to
February 14, 2023
General Issues: Financial Institutions/Investments/Securities , Taxation/Internal Revenue Code , Agriculture , Banking , Budget/Appropriations , Veterans , Health Issues
Spending: about $565,000 (But it's complicated. Here's why.)
It can be tricky to figure out how much an organization spent on a particular lobbying engagement. The law only requires lobbyists to report the amount they were paid for federal lobbying each quarter rounded to the nearest $10,000—and if it's less than $3,000 in a given quarter (or less than $13,000 for organizations with in-house lobbyists), they don't have to disclose it at all. Plus, some organizations include spending that doesn’t belong in the report—for instance, money spent lobbying state governments or other legal work.
Agencies lobbied since 2018: House of Representatives, U.S. Senate, Agriculture - Dept of (USDA), Environmental Protection Agency (EPA)
Lobbyists
Lobbyists named here were listed on a filing related to this lobbying engagement. They may not be working on it now. Occasionally, a single lobbyist whose name is spelled two different ways on filings may be represented twice here.
Disclosures Filed
Once a lobbying engagement begins, the lobbyist or firm is required to file updates four times a year. Those updates sometimes change which lobbyists are involved or add new issues being discussed. When lobbyists stop working for a client, the firm is also supposed to file a report disclosing the end of the relationship.
1st Quarter, 2023
GREAT POINT STRATEGIES, LLC terminated an engagement in which they represented PharmaCann on Sept. 8, 2023.
Original Filing: 301496122.xml
Agencies Lobbied
U.S. House of Representatives
Type of Issue
Financial Institutions/Investments/Securities
Type of Issue
Taxation/Internal Revenue Code
1st Quarter, 2023
GREAT POINT STRATEGIES, LLC terminated an engagement in which they represented PharmaCann on Feb. 15, 2023.
Original Filing: 301446633.xml
4th Quarter, 2022
In Q4, GREAT POINT STRATEGIES, LLC lobbied for PharmaCann , earning $30,000. The report was filed on Jan. 23, 2023.
Original Filing: 301444728.xml
Lobbying Issues
H.R. 1996-SAFE Banking Act
Agencies Lobbied
U.S. House of Representatives
Type of Issue
Financial Institutions/Investments/Securities
Lobbying Issues
280e Tax Provisions on licensed cannabis companies
Agencies Lobbied
U.S. Senate
Type of Issue
Taxation/Internal Revenue Code
Lobbying Issues
H.R.841 - Hemp and Hemp-Derived CBD Consumer Protection and Market Stabilization Act of 2021
Agencies Lobbied
U.S. House of Representatives
3rd Quarter, 2022
In Q3, GREAT POINT STRATEGIES, LLC lobbied for PharmaCann , earning $30,000. The report was filed on Sept. 26, 2022.
Original Filing: 301400461.xml
Lobbying Issues
H.R. 1996-SAFE Banking Act
Agencies Lobbied
U.S. House of Representatives
Type of Issue
Financial Institutions/Investments/Securities
Lobbying Issues
280e Tax Provisions on licensed cannabis companies
Agencies Lobbied
U.S. Senate
Type of Issue
Taxation/Internal Revenue Code
Lobbying Issues
H.R.841 - Hemp and Hemp-Derived CBD Consumer Protection and Market Stabilization Act of 2021
Agencies Lobbied
U.S. House of Representatives
2nd Quarter, 2022
In Q2, GREAT POINT STRATEGIES, LLC lobbied for PharmaCann , earning $30,000. The report was filed on Aug. 8, 2022.
Original Filing: 301398484.xml
Lobbying Issues
H.R. 1996-SAFE Banking Act
Agencies Lobbied
U.S. House of Representatives
Type of Issue
Financial Institutions/Investments/Securities
Lobbying Issues
280e Tax Provisions on licensed cannabis companies
Agencies Lobbied
U.S. Senate
Type of Issue
Taxation/Internal Revenue Code
Lobbying Issues
H.R.841 - Hemp and Hemp-Derived CBD Consumer Protection and Market Stabilization Act of 2021
Agencies Lobbied
U.S. House of Representatives
1st Quarter, 2022
GREAT POINT STRATEGIES, LLC amended a lobbying report for representation of PharmaCann in Q12022 on June 6, 2022.
Original Filing: 301376208.xml
Lobbying Issues
H.R. 1996-SAFE Banking Act
Agencies Lobbied
U.S. House of Representatives
Type of Issue
Financial Institutions/Investments/Securities
Lobbying Issues
280e Tax Provisions on licensed cannabis companies
Agencies Lobbied
U.S. Senate
Type of Issue
Taxation/Internal Revenue Code
Lobbying Issues
H.R.841 - Hemp and Hemp-Derived CBD Consumer Protection and Market Stabilization Act of 2021
Agencies Lobbied
U.S. House of Representatives
1st Quarter, 2022
In Q1, GREAT POINT STRATEGIES, LLC lobbied for PharmaCann , earning $30,000. The report was filed on May 6, 2022.
Original Filing: 301374478.xml
Lobbying Issues
H.R. 1996-SAFE Banking Act
Agencies Lobbied
U.S. House of Representatives
Type of Issue
Financial Institutions/Investments/Securities
Lobbying Issues
280e Tax Provisions on licensed cannabis companies
Agencies Lobbied
U.S. Senate
Type of Issue
Taxation/Internal Revenue Code
Lobbying Issues
H.R.841 - Hemp and Hemp-Derived CBD Consumer Protection and Market Stabilization Act of 2021
Agencies Lobbied
U.S. House of Representatives
4th Quarter, 2021
In Q4, GREAT POINT STRATEGIES, LLC lobbied for PharmaCann , earning $30,000. The report was filed on Jan. 18, 2022.
Original Filing: 301324719.xml
Lobbying Issues
H.R. 1996-SAFE Banking Act
Agencies Lobbied
U.S. House of Representatives
Type of Issue
Financial Institutions/Investments/Securities
Lobbying Issues
280e Tax Provisions on licensed cannabis companies
Agencies Lobbied
U.S. Senate
Type of Issue
Taxation/Internal Revenue Code
Lobbying Issues
H.R.841 - Hemp and Hemp-Derived CBD Consumer Protection and Market Stabilization Act of 2021
Agencies Lobbied
U.S. House of Representatives
3rd Quarter, 2021
In Q3, GREAT POINT STRATEGIES, LLC lobbied for PharmaCann , earning $30,000. The report was filed on Oct. 18, 2021.
Original Filing: 301301117.xml
Lobbying Issues
H.R. 1996-SAFE Banking Act
Agencies Lobbied
U.S. House of Representatives
Type of Issue
Financial Institutions/Investments/Securities
Lobbying Issues
280e Tax Provisions on licensed cannabis companies
Agencies Lobbied
U.S. Senate
Type of Issue
Taxation/Internal Revenue Code
Lobbying Issues
H.R.841 - Hemp and Hemp-Derived CBD Consumer Protection and Market Stabilization Act of 2021
Agencies Lobbied
U.S. House of Representatives
2nd Quarter, 2021
In Q2, GREAT POINT STRATEGIES, LLC lobbied for PharmaCann , earning $30,000. The report was filed on June 30, 2021.
Original Filing: 301273080.xml
Lobbying Issues
H.R. 1996-SAFE Banking Act
Agencies Lobbied
U.S. House of Representatives
Type of Issue
Financial Institutions/Investments/Securities
Lobbying Issues
280e Tax Provisions on licensed cannabis companies
Agencies Lobbied
U.S. Senate
Type of Issue
Taxation/Internal Revenue Code
Lobbying Issues
H.R.841 - Hemp and Hemp-Derived CBD Consumer Protection and Market Stabilization Act of 2021
Agencies Lobbied
U.S. House of Representatives
1st Quarter, 2021
In Q1, GREAT POINT STRATEGIES, LLC lobbied for PharmaCann , earning $30,000. The report was filed on April 20, 2021.
Original Filing: 301261292.xml
Lobbying Issues
H.R. 1996-SAFE Banking Act
Agencies Lobbied
U.S. House of Representatives
Type of Issue
Financial Institutions/Investments/Securities
Lobbying Issues
280e Tax Provisions on licensed cannabis companies
Agencies Lobbied
U.S. Senate
Type of Issue
Taxation/Internal Revenue Code
Lobbying Issues
H.R.841 - Hemp and Hemp-Derived CBD Consumer Protection and Market Stabilization Act of 2021
Agencies Lobbied
U.S. House of Representatives
4th Quarter, 2020
In Q4, GREAT POINT STRATEGIES, LLC lobbied for PharmaCann , earning $30,000. The report was filed on Jan. 24, 2021.
Original Filing: 301246435.xml
Lobbying Issues
HR 1595 Secure And Fair Enforcement Banking Act of 2019, To create protections for depository institutions that provide financial services to cannabis-related legitimate businesses and service providers for such businesses, and for other purposes.
Agencies Lobbied
U.S. House of Representatives
Type of Issue
Financial Institutions/Investments/Securities
Lobbying Issues
HR 1118, Small Business Tax Equity Act of 2019, exempts a trade or business that conducts marijuana sales in compliance with state law from a provision in the Internal Revenue Code that prohibits business-related tax credits or deductions for expenditures in connection with trafficking in controlled substances.
Agencies Lobbied
U.S. Senate
Type of Issue
Taxation/Internal Revenue Code
Lobbying Issues
Rule making for hemp program in the Agriculture Improvement Act of 2018
Agencies Lobbied
Agriculture - Dept of (USDA)
3rd Quarter, 2020
In Q3, GREAT POINT STRATEGIES, LLC lobbied for PharmaCann , earning $30,000. The report was filed on Oct. 20, 2020.
Original Filing: 301218104.xml
Lobbying Issues
HR 1595 Secure And Fair Enforcement Banking Act of 2019, To create protections for depository institutions that provide financial services to cannabis-related legitimate businesses and service providers for such businesses, and for other purposes.
Agencies Lobbied
U.S. House of Representatives
Type of Issue
Financial Institutions/Investments/Securities
Lobbying Issues
HR 1118, Small Business Tax Equity Act of 2019, exempts a trade or business that conducts marijuana sales in compliance with state law from a provision in the Internal Revenue Code that prohibits business-related tax credits or deductions for expenditures in connection with trafficking in controlled substances.
Agencies Lobbied
U.S. Senate
Type of Issue
Taxation/Internal Revenue Code
Lobbying Issues
Rule making for hemp program in the Agriculture Improvement Act of 2018
Agencies Lobbied
Agriculture - Dept of (USDA)
2nd Quarter, 2020
In Q2, GREAT POINT STRATEGIES, LLC lobbied for PharmaCann , earning $30,000. The report was filed on July 17, 2020.
Original Filing: 301190536.xml
Lobbying Issues
HR 1595 Secure And Fair Enforcement Banking Act of 2019, To create protections for depository institutions that provide financial services to cannabis-related legitimate businesses and service providers for such businesses, and for other purposes.
Agencies Lobbied
U.S. House of Representatives
Type of Issue
Financial Institutions/Investments/Securities
Lobbying Issues
HR 1118, Small Business Tax Equity Act of 2019, exempts a trade or business that conducts marijuana sales in compliance with state law from a provision in the Internal Revenue Code that prohibits business-related tax credits or deductions for expenditures in connection with trafficking in controlled substances.
Agencies Lobbied
U.S. Senate
Type of Issue
Taxation/Internal Revenue Code
Lobbying Issues
Rule making for hemp program in the Agriculture Improvement Act of 2018
Agencies Lobbied
Agriculture - Dept of (USDA)
1st Quarter, 2020
In Q1, GREAT POINT STRATEGIES, LLC lobbied for PharmaCann , earning $30,000. The report was filed on April 21, 2020.
Original Filing: 301180681.xml
Lobbying Issues
HR 1595 Secure And Fair Enforcement Banking Act of 2019, To create protections for depository institutions that provide financial services to cannabis-related legitimate businesses and service providers for such businesses, and for other purposes.
Agencies Lobbied
U.S. House of Representatives
Type of Issue
Financial Institutions/Investments/Securities
Lobbying Issues
HR 1118, Small Business Tax Equity Act of 2019, exempts a trade or business that conducts marijuana sales in compliance with state law from a provision in the Internal Revenue Code that prohibits business-related tax credits or deductions for expenditures in connection with trafficking in controlled substances.
Agencies Lobbied
U.S. Senate
Type of Issue
Taxation/Internal Revenue Code
Lobbying Issues
Rule making for hemp program in the Agriculture Improvement Act of 2018
Agencies Lobbied
Agriculture - Dept of (USDA)
4th Quarter, 2019
In Q4, GREAT POINT STRATEGIES, LLC lobbied for PharmaCann , earning $30,000. The report was filed on Jan. 20, 2020.
Original Filing: 301122437.xml
Lobbying Issues
HR 1595 Secure And Fair Enforcement Banking Act of 2019, To create protections for depository institutions that provide financial services to cannabis-related legitimate businesses and service providers for such businesses, and for other purposes.
Agencies Lobbied
U.S. House of Representatives
Type of Issue
Financial Institutions/Investments/Securities
Lobbying Issues
HR 1118, Small Business Tax Equity Act of 2019, exempts a trade or business that conducts marijuana sales in compliance with state law from a provision in the Internal Revenue Code that prohibits business-related tax credits or deductions for expenditures in connection with trafficking in controlled substances.
Agencies Lobbied
U.S. Senate
Type of Issue
Taxation/Internal Revenue Code
Lobbying Issues
Rule making for hemp program in the Agriculture Improvement Act of 2018
Agencies Lobbied
Agriculture - Dept of (USDA)
3rd Quarter, 2019
In Q3, GREAT POINT STRATEGIES, LLC lobbied for PharmaCann , earning $30,000. The report was filed on Oct. 20, 2019.
Original Filing: 301072792.xml
Lobbying Issues
HR 1595 Secure And Fair Enforcement Banking Act of 2019, To create protections for depository institutions that provide financial services to cannabis-related legitimate businesses and service providers for such businesses, and for other purposes.
Agencies Lobbied
U.S. House of Representatives
Type of Issue
Financial Institutions/Investments/Securities
Lobbying Issues
HR 1118, Small Business Tax Equity Act of 2019, exempts a trade or business that conducts marijuana sales in compliance with state law from a provision in the Internal Revenue Code that prohibits business-related tax credits or deductions for expenditures in connection with trafficking in controlled substances.
Agencies Lobbied
U.S. Senate
Type of Issue
Taxation/Internal Revenue Code
Lobbying Issues
Rule making for hemp program in the Agriculture Improvement Act of 2018
Agencies Lobbied
Agriculture - Dept of (USDA)
2nd Quarter, 2019
In Q2, GREAT POINT STRATEGIES, LLC lobbied for PharmaCann , earning $30,000. The report was filed on July 19, 2019.
Original Filing: 301051315.xml
Lobbying Issues
HR 1595 Secure And Fair Enforcement Banking Act of 2019, To create protections for depository institutions that provide financial services to cannabis-related legitimate businesses and service providers for such businesses, and for other purposes.
Agencies Lobbied
U.S. House of Representatives
Type of Issue
Financial Institutions/Investments/Securities
Lobbying Issues
HR 1118, Small Business Tax Equity Act of 2019, exempts a trade or business that conducts marijuana sales in compliance with state law from a provision in the Internal Revenue Code that prohibits business-related tax credits or deductions for expenditures in connection with trafficking in controlled substances.
Agencies Lobbied
U.S. Senate
Type of Issue
Taxation/Internal Revenue Code
Lobbying Issues
Rule making for hemp program in the Agriculture Improvement Act of 2018
Agencies Lobbied
Agriculture - Dept of (USDA)
1st Quarter, 2019
In Q1, GREAT POINT STRATEGIES, LLC lobbied for PharmaCann , earning $30,000. The report was filed on April 19, 2019.
Original Filing: 301030785.xml
Lobbying Issues
HR 1595 Secure And Fair Enforcement Banking Act of 2019, To create protections for depository institutions that provide financial services to cannabis-related legitimate businesses and service providers for such businesses, and for other purposes.
Agencies Lobbied
U.S. House of Representatives
Type of Issue
Financial Institutions/Investments/Securities
Lobbying Issues
HR 1118, Small Business Tax Equity Act of 2019, exempts a trade or business that conducts marijuana sales in compliance with state law from a provision in the Internal Revenue Code that prohibits business-related tax credits or deductions for expenditures in connection with trafficking in controlled substances.
Agencies Lobbied
U.S. Senate
Type of Issue
Taxation/Internal Revenue Code
Lobbying Issues
Rule making for hemp program in the Agriculture Improvement Act of 2018
Agencies Lobbied
Agriculture - Dept of (USDA)
4th Quarter, 2018
In Q4, GREAT POINT STRATEGIES, LLC lobbied for PharmaCann , earning $30,000. The report was filed on Jan. 20, 2019.
Original Filing: 301011144.xml
Lobbying Issues
H.R.6043 - STATES Act: To amend the Controlled Substances Act to provide for a new rule regarding the application of the Act to marihuana, and for other purposes.
S.3032 - STATES Act: To amend the Controlled Substances Act to provide for a new rule regarding the application of the Act to marihuana, and for other purposes.
H.R. 2215- Secure and Fair Enforcement Banking Act of 2017 or the SAFE Act of 2017
Agencies Lobbied
U.S. House of Representatives
Type of Issue
Financial Institutions/Investments/Securities
Lobbying Issues
H.R.6043 - STATES Act: To amend the Controlled Substances Act to provide for a new rule regarding the application of the Act to marihuana, and for other purposes.
S.3032 - STATES Act: To amend the Controlled Substances Act to provide for a new rule regarding the application of the Act to marihuana, and for other purposes.
H.R. 2215- Secure and Fair Enforcement Banking Act of 2017 or the SAFE Act of 2017
Agencies Lobbied
U.S. Senate
Type of Issue
Taxation/Internal Revenue Code
3rd Quarter, 2018
In Q3, GREAT POINT STRATEGIES, LLC lobbied for PharmaCann , earning $30,000. The report was filed on Oct. 18, 2018.
Original Filing: 300988454.xml
Lobbying Issues
H.R.6043 - STATES Act: To amend the Controlled Substances Act to provide for a new rule regarding the application of the Act to marihuana, and for other purposes.
S.3032 - STATES Act: To amend the Controlled Substances Act to provide for a new rule regarding the application of the Act to marihuana, and for other purposes.
H.R. 2215- Secure and Fair Enforcement Banking Act of 2017 or the SAFE Act of 2017
Agencies Lobbied
U.S. House of Representatives
Type of Issue
Financial Institutions/Investments/Securities
Lobbying Issues
H.R.6043 - STATES Act: To amend the Controlled Substances Act to provide for a new rule regarding the application of the Act to marihuana, and for other purposes.
S.3032 - STATES Act: To amend the Controlled Substances Act to provide for a new rule regarding the application of the Act to marihuana, and for other purposes.
H.R. 2215- Secure and Fair Enforcement Banking Act of 2017 or the SAFE Act of 2017
Agencies Lobbied
U.S. Senate
Type of Issue
Taxation/Internal Revenue Code
2nd Quarter, 2018
In Q2, GREAT POINT STRATEGIES, LLC lobbied for PharmaCann , earning $15,000. The report was filed on July 23, 2018.
Original Filing: 300979054.xml
Lobbying Issues
H.R.6043 - STATES Act: To amend the Controlled Substances Act to provide for a new rule regarding the application of the Act to marihuana, and for other purposes.
S.3032 - STATES Act: To amend the Controlled Substances Act to provide for a new rule regarding the application of the Act to marihuana, and for other purposes.
H.R. 2215- Secure and Fair Enforcement Banking Act of 2017 or the SAFE Act of 2017
Agencies Lobbied
U.S. House of Representatives
Type of Issue
Financial Institutions/Investments/Securities
Lobbying Issues
H.R.6043 - STATES Act: To amend the Controlled Substances Act to provide for a new rule regarding the application of the Act to marihuana, and for other purposes.
S.3032 - STATES Act: To amend the Controlled Substances Act to provide for a new rule regarding the application of the Act to marihuana, and for other purposes.
H.R. 2215- Secure and Fair Enforcement Banking Act of 2017 or the SAFE Act of 2017
Agencies Lobbied
U.S. Senate
Type of Issue
Taxation/Internal Revenue Code
2nd Quarter, 2018
GREAT POINT STRATEGIES, LLC filed a lobbying registration on June 11, 2018 to represent PharmaCann, effective May 15, 2018.
Original Filing: 300961219.xml
Issue(s) they said they’d lobby about: S1152 / HR2215, 'Secure and Fair Enforcement Banking Act of 2017 .
Source: Clerk of the U.S. House of Representatives and Secretary of the Senate
Searching...